Jan. 24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...

A large majority of high-grade lesions in the female genital tract emerge as monoclonal cell populations derived from the cervical transformation zone. Molecular Transformation Events Induced by ...

A total of 246 cases with objective evidence of benign cervical lesions were divided into 2 ... as compared with patients in group B, who reported high satisfaction (77.5%) and good tolerability ...

The Papanicolaou (Pap) smear is commonly used to screen for cervical cancer and since its ... US Food and Drug Administration to screen for high-grade cervical intraepithelial neoplasia.